RACHEL CARLSON: Open Payments
NPI 1043253321 · PARADISE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,260 in 10 payments from 8 companies in 2025. Trend: 2023 $721 · 2024 $893 · 2025 $1,260
Food & beverage: $1,260
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $271 |
| E.R. Squibb & Sons, L.L.C. | 2 | $221 |
| Boston Scientific Corporation | 1 | $183 |
| Caris MPI, Inc. | 1 | $127 |
| Adaptive Biotechnologies Corporation | 1 | $126 |
| Daiichi Sankyo Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP | 1 | $85 |
Products named: RYBREVANT, OPDIVO, Axios, MI CANCER SEEK, clonoSEQ, Enhertu, VENCLEXTA, LYNPARZA.
Industry payments across CA — which companies pay providers there.
